resource-symbol

Fibromyalgia Rapid Screening Tool (FiRST)

Perrot Serge; Bouhassira D

Distributed by Mapi Research Trust

Distributed by Mapi Research Trust

default distrib
 

Basic description

Developed in 2010

Authors

Perrot Serge; Bouhassira D

Copyright
FiRST© Serge Perrot, Didier Bouhassira, REDAR, 2010. All rights reserved
Objective
Screening tool developed for the detection of fibromyalgia syndrome in patients with diffuse chronic pain
Therapeutic area
  • Nervous System Diseases
  • Musculoskeletal Diseases
Therapeutic indication

Fibromyalgia

Type of Clinical Outcome Assessment (COA)
  • PRO PRO
Original language(s)
  • English for the UK
  • French for France
Bibliographic reference(s) of the original questionnaire

Perrot S, Bouhassira D, Fermanian J. Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST). Pain. 2010 Aug;150(2):250-6 (PubMed abstract)


Contact and conditions of use

Authors

Perrot Serge; Bouhassira D

Prof. Serge Perrot
Service de Médecine Interne et Thérapeutique
INSERM  U987
Hôpital Hôtel Dieu
1 Place du Parvis Notre Dame
75004 PARIS
France
Phone: +33 1 42 34 84 49
E-mail: serge.perrot@htd.aphp.fr

Perrot Serge publications (PubMed)

    

Dr. Didier Bouhassira
INSERM U987
« Pathophysiology and Clinical Pharmacology of Pain »
Centre d’Evaluation et de Traitement de la Douleur
Hôpital Ambroise Paré
9, Avenue Charles de Gaulle
92100 Boulogne-Billancourt
France
Phone: +33 1 49 09 45 56
Fax: +33 1 49 09 44 35
E-mail: didier.bouhassira@inserm.fr

Bouhassira D publications (PubMed)

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Non-Commercial Users

If you do not receive specific funding for your study, you may download the questionnaire directly:

  1. Log in or Register for free
  2. Click the 'Online distribution' tab in the left menu bar and follow the instructions

Tutorials are available on our FAQs.

Commercial Users

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. In order to accelerate the process, you may attach the User Agreement (even if not finalized) to your online request. Click the link below for the user agreement template.
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

Access fees

ROYALTY FEES* Commercial users Cost per study 500 € (use in commercial epidemiologic / observational / marketing studies: please consult the User Agreement)
Cost per language 500 € (use in commercial epidemiologic / observational / marketing studies: please consult the User Agreement)
Funded academic research Cost per study Free
Cost per language Free
Not funded academic users Cost per study Free
Cost per language Free
DISTRIBUTION FEES* Commercial users Cost per study 1 000 €
Cost per language 500 €
Funded academic research Cost per study 300 €
Cost per language 50 €
Not funded academic users Cost per study Free
Cost per language Free

* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds

Transfer of rights to use and reproduce the Questionnaire

(Owner’sRoyalty Fees)

COMMERCIAL USERS

in clinical studies / projects

COST PER STUDY

550 Euros*

COST PER LANGUAGE

550 Euros*

FUNDED ACADEMIC RESEARCH

in clinical studies / projects

COST PER STUDY

n/a

COST PER LANGUAGE

n/a

COMMERCIAL USERS

in commercial epidemiologic/ observational/ marketing studies /  projects

COST PER STUDY

550 Euros*

COST PER LANGUAGE

550 Euros*

Up to 1000 administrations/ reproductions:

2.20 Euros* per administration/ reproduction

Between 1001 and 2500 administrations/ reproductions:

2  Euros* per administration/ reproduction

Between 2501 and 5000 administrations/ reproductions:

1.75 Euros* per administration/ reproduction

From 5001 administrations/ reproductions:

1.55 * Euros per administration/ reproduction

MRT’s Distribution Costs

COMMERCIAL USERS

COST PER STUDY

1 000 Euros*

COST PER AVAILABLE LANGUAGE

500 Euros*

FUNDED ACADEMIC USERS

COST PER STUDY

300 Euros*

COST PER AVAILABLE LANGUAGE

50 Euros*

NOT FUNDED ACADEMIC USERS

COST PER STUDY

n/a

COST PER AVAILABLE LANGUAGE

n/a

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Online distribution

For Non-Funded Academic Studies

The following licensing process is restricted to academic users:

  • Who do not receive specific funding for their study
  • Who intend to use the questionnaire in individual clinical practice or research study

Should you not correspond to this category of users, please send us a request.

Note: This site aims at providing you with the original version and existing translations of the questionnaire. However some modules/versions may not be downloadable in the language you need.

If you are interested in specific language(s), please first consult the list of existing translations in PROQOLID.

Login

To access this section, please complete a client account.

Languages

Original language(s)

  • English for the UK
  • French for France

Translations

The translations listed may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

FiRST

Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for the USA*
French for Belgium*
Greek for Greece*
Italian for Italy*
Portuguese for Portugal*
Russian for Russia*
Spanish for Spain*
Turkish for Turkey
* Performed by Mapi

The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi

More information on translations

Bibliographic reference of the Turkish translation:

Celiker et al. Reliability and validity of the Turkish version of the fibromyalgia rapid screening tool (FiRST). J. Phys. Ther. Sci. 29:340–344, 2017 (Full text article)

Last update: March 2017
For additional information, please submit a request. More information in our FAQs.